Sunil Nagpal

Tazarotene-induced Gene 2 (TIG2), a Novel Retinoid-Responsive Gene in Skin

Sunil Nagpal, Sheetal Patel, Heidi Jacobe et al. · Journal of Investigative Dermatology · 1997 · 298 citations · Full text

Life Sciences, Genetics, Molecular Biology +10

Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study

Kieron Dunleavy, Michelle A. Fanale, Ariela Noy et al. · The Lancet Haematology · 2018 · 232 citations

Medicine, Oncology, Pharmacology +11

LXR modulation blocks prostaglandin E ₂ production and matrix degradation in cartilage and alleviates pain in a rat osteoarthritis model

Ning Li, M.A. Rivera-Bermudez, Mei Zhang et al. · Proceedings of the National Academy of Sciences · 2010 · 78 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Expression of a retinoid-inducible tumor suppressor, Tazarotene-inducible gene-3, is decreased in psoriasis and skin cancer.

Madeleine Duvic, B Helekar, Claudia Schulz et al. · PubMed · 2000 · 77 citations

Life Sciences, Dermatology, Genetics +15

Differential Biochemical and Cellular Actions of Premarin Estrogens: Distinct Pharmacology of Bazedoxifene-Conjugated Estrogens Combination

Thomas J. Berrodin, Ken C. N. Chang, Barry S. Komm et al. · Molecular Endocrinology · 2008 · 70 citations · Full text

Life Sciences, Endocrinology, Pharmacology +15